We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Doctor To Back Off Drug Trials Amid Ethics Probe

Law360 (December 31, 2008, 12:00 AM EST) -- A renowned psychiatrist has agreed to halt his participation in several industry-funded clinical trials in the wake of allegations that he worked with Johnson & Johnson to create a research center that promoted the company's anti-psychotic drug Risperdal for use among children.

Massachusetts General Hospital physician Joseph Biederman will curb his involvement in the research pending the outcome of the hospital's inquiry into his “potential conflicts of interest, disclosure and industry-institutional relationships,” the hospital said in a statement Monday.

Under the agreement, Biederman will stop involvement...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.